Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion. Strong transaction support, with a unanimous...
Hence then, the article about samsung biologics announces all cash offer to acquire polypeptide accelerating multi modality strategy and expanding global network across u s europe and india was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India )
Also on site :
- What channel is Barnsley v Leicester City League One match on? TV coverage, live stream and kick-off time
- The Gates Foundation is spending $400 million on AI in schools. Teachers warn it could ‘end up widening’ the divide it’s meant to close
- What channel is Burton Albion v Mansfield Town League One match on? TV coverage, live stream and kick-off time